CD4 and neoplasm: Yet, tumor cells may engage various escape mechanisms to acquire resistance to this response, which include induction of CD4+ T cell phenotype switching from proinflammatory anti-neoplastic TH1 cells into immunosuppressive and thus tumor growth-promoting Tregs (105).